Macrolides in Chronic Inflammatory Skin Disorders
Joint Authors
Alzolibani, Abdullateef A.
Zedan, Khaled
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-05-17
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Long-term therapy with the macrolide antibiotic erythromycin was shown to alter the clinical course of diffuse panbronchiolitis in the late 1980s.
Since that time, macrolides have been found to have a large number of anti-inflammatory properties in addition to being antimicrobials.
These observations provided the rationale for many studies performed to assess the usefulness of macrolides in other inflammatory diseases including skin and hair disorders, such as rosacea, psoriasis, pityriasis rosea, alopecia areata, bullous pemphigoid, and pityriasis lichenoides.
This paper summarizes a collection of clinical studies and case reports dealing with the potential benefits of macrolides antibiotics in the treatment of selected dermatoses which have primarily been classified as noninfectious and demonstrating their potential for being disease-modifying agents.
American Psychological Association (APA)
Alzolibani, Abdullateef A.& Zedan, Khaled. 2012. Macrolides in Chronic Inflammatory Skin Disorders. Mediators of Inflammation،Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-998839
Modern Language Association (MLA)
Alzolibani, Abdullateef A.& Zedan, Khaled. Macrolides in Chronic Inflammatory Skin Disorders. Mediators of Inflammation No. 2012 (2012), pp.1-7.
https://search.emarefa.net/detail/BIM-998839
American Medical Association (AMA)
Alzolibani, Abdullateef A.& Zedan, Khaled. Macrolides in Chronic Inflammatory Skin Disorders. Mediators of Inflammation. 2012. Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-998839
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-998839